Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas

T Chung; J Na; Y-I Kim; D-Y Chang; YI Kim; H Kim; HE Moon; KW Kang; DS Lee; J-K Chung; S-S Kim; H Suh-Kim; SH Paek; H Youn

doi:10.7150/thno.14158

Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas

T Chung
, J Na
, Y-I Kim
, D-Y Chang
, YI Kim
, H Kim
, HE Moon
, KW Kang
, DS Lee
, J-K Chung
, S-S Kim
, H Suh-Kim
, SH Paek
, H Youn

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1477-1490
Number of pages	0
Journal	Theranostics
Volume	6
Issue number	10
DOIs	https://doi.org/10.7150/thno.14158
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7150/thno.14158

Cite this

Chung, T., Na, J., Kim, Y.-I., Chang, D.-Y., Kim, YI., Kim, H., Moon, HE., Kang, KW., Lee, DS., Chung, J.-K., Kim, S.-S., Suh-Kim, H., Paek, SH., & Youn, H. (2016). Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas. Theranostics, 6(10), 1477-1490. https://doi.org/10.7150/thno.14158

@article{be0b23a45054460bb9e7bd04b18d6b8e,

title = "Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas",

author = "T Chung and J Na and Y-I Kim and D-Y Chang and YI Kim and H Kim and HE Moon and KW Kang and DS Lee and J-K Chung and S-S Kim and H Suh-Kim and SH Paek and H Youn",

year = "2016",

doi = "10.7150/thno.14158",

language = "English",

volume = "6",

pages = "1477--1490",

journal = "Theranostics",

issn = "1838-7640",

publisher = "Ivyspring International Publisher",

number = "10",

}

Chung, T, Na, J, Kim, Y-I, Chang, D-Y, Kim, YI, Kim, H, Moon, HE, Kang, KW, Lee, DS, Chung, J-K, Kim, S-S, Suh-Kim, H, Paek, SH & Youn, H 2016, 'Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas', Theranostics, vol. 6, no. 10, pp. 1477-1490. https://doi.org/10.7150/thno.14158

TY - JOUR

T1 - Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas

AU - Chung, T

AU - Na, J

AU - Kim, Y-I

AU - Chang, D-Y

AU - Kim, YI

AU - Kim, H

AU - Moon, HE

AU - Kang, KW

AU - Lee, DS

AU - Chung, J-K

AU - Kim, S-S

AU - Suh-Kim, H

AU - Paek, SH

AU - Youn, H

PY - 2016

Y1 - 2016

U2 - 10.7150/thno.14158

DO - 10.7150/thno.14158

M3 - Article

SN - 1838-7640

VL - 6

SP - 1477

EP - 1490

JO - Theranostics

JF - Theranostics

IS - 10

ER -